Thank you!

Your email has been successfully added to our mailing list.

×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks

SRPT – sarepta therapeutics, inc. (US:NASDAQ)

DELAYED 04:44 PM EDT 04/17/25
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
173.25
06/23/24
52 Week Low
48.01
04/10/25
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SRPT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/13
08:00 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 12 Filed by: Nicaise Claude
Low Report
Form 4 Sarepta Therapeutics, For: Mar 12 Filed by: Nicaise Claude
Report
3/12
05:33 pm
srpt
Form 144 Sarepta Therapeutics, Filed by: Nicaise Claude
Low Report
Form 144 Sarepta Therapeutics, Filed by: Nicaise Claude
Report
3/11
08:00 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 10 Filed by: Mayo Stephen
Low Report
Form 4 Sarepta Therapeutics, For: Mar 10 Filed by: Mayo Stephen
Report
3/11
08:00 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 10 Filed by: Connelly Deirdre P
Low Report
Form 4 Sarepta Therapeutics, For: Mar 10 Filed by: Connelly Deirdre P
Report
3/11
08:00 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 10 Filed by: Arif Bilal
Low Report
Form 4 Sarepta Therapeutics, For: Mar 10 Filed by: Arif Bilal
Report
3/11
08:00 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 10 Filed by: Rothfuss Cristin
Low Report
Form 4 Sarepta Therapeutics, For: Mar 10 Filed by: Rothfuss Cristin
Report
3/11
08:00 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 07 Filed by: Murray Dallan
Low Report
Form 4 Sarepta Therapeutics, For: Mar 07 Filed by: Murray Dallan
Report
3/11
08:00 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 10 Filed by: Barry Richard
Low Report
Form 4 Sarepta Therapeutics, For: Mar 10 Filed by: Barry Richard
Report
3/11
08:00 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 10 Filed by: Boor Kathryn Jean
Low Report
Form 4 Sarepta Therapeutics, For: Mar 10 Filed by: Boor Kathryn Jean
Report
3/11
08:00 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 10 Filed by: Chambers Michael Andrew
Low Report
Form 4 Sarepta Therapeutics, For: Mar 10 Filed by: Chambers Michael Andrew
Report
3/11
08:00 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 07 Filed by: Rodino-Klapac Louise
Low Report
Form 4 Sarepta Therapeutics, For: Mar 07 Filed by: Rodino-Klapac Louise
Report
3/11
08:00 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 10 Filed by: Wigzell Hans Lennart Rudolf
Low Report
Form 4 Sarepta Therapeutics, For: Mar 10 Filed by: Wigzell Hans Lennart Rudolf
Report
3/11
08:00 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 10 Filed by: BEHRENS M KATHLEEN
Low Report
Form 4 Sarepta Therapeutics, For: Mar 10 Filed by: BEHRENS M KATHLEEN
Report
3/11
08:00 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 10 Filed by: Nicaise Claude
Low Report
Form 4 Sarepta Therapeutics, For: Mar 10 Filed by: Nicaise Claude
Report
3/11
08:00 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 07 Filed by: Estepan Ian Michael
Low Report
Form 4 Sarepta Therapeutics, For: Mar 07 Filed by: Estepan Ian Michael
Report
3/10
08:00 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 07 Filed by: Rothfuss Cristin
Low Report
Form 4 Sarepta Therapeutics, For: Mar 07 Filed by: Rothfuss Cristin
Report
3/10
08:00 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 06 Filed by: Arif Bilal
Low Report
Form 4 Sarepta Therapeutics, For: Mar 06 Filed by: Arif Bilal
Report
3/10
08:00 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 06 Filed by: Murray Dallan
Low Report
Form 4 Sarepta Therapeutics, For: Mar 06 Filed by: Murray Dallan
Report
3/10
08:00 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 06 Filed by: Rodino-Klapac Louise
Low Report
Form 4 Sarepta Therapeutics, For: Mar 06 Filed by: Rodino-Klapac Louise
Report
3/10
08:00 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 06 Filed by: Estepan Ian Michael
Low Report
Form 4 Sarepta Therapeutics, For: Mar 06 Filed by: Estepan Ian Michael
Report
3/6
08:00 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 04 Filed by: Arif Bilal
Medium Report
Form 4 Sarepta Therapeutics, For: Mar 04 Filed by: Arif Bilal
Report
3/6
08:00 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 04 Filed by: Rothfuss Cristin
Medium Report
Form 4 Sarepta Therapeutics, For: Mar 04 Filed by: Rothfuss Cristin
Report
3/6
08:00 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 04 Filed by: Murray Dallan
Medium Report
Form 4 Sarepta Therapeutics, For: Mar 04 Filed by: Murray Dallan
Report
3/6
08:00 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 04 Filed by: Rodino-Klapac Louise
Medium Report
Form 4 Sarepta Therapeutics, For: Mar 04 Filed by: Rodino-Klapac Louise
Report
3/6
08:00 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 04 Filed by: Estepan Ian Michael
Medium Report
Form 4 Sarepta Therapeutics, For: Mar 04 Filed by: Estepan Ian Michael
Report
Latest Posts

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day
Information

Information

Support

Support

Contact us

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com
Stay in the know news, product updates and promotions.
Copyright Ⓒ News Quanitifed LLC 2012-2025, All product trademarks, names, logos, and brands are property of their respective owners. Image(s) or Footage (as applicable), used under license from Shutterstock.com. 3.0.0